If your primary concern is metabolic health, blood sugar regulation, and exercise performance, MOTS-C may be the better fit
Other GLP-1 receptor agonists available in the UK include dulaglutide (Trulicity), liraglutide (Victoza), exenatide (Byetta, Bydureon), and tirzepatide (Mounjaro), which share similar mechanisms of action but differ in dosing frequency and pharmacokinetic profiles
The analyses revealed sex-specific reporting patterns, consumer-driven pharmacovigilance, and early-onset NAE manifestations
53 LR] Roche announces positive Phase II results for its dual GLP-1/GIP receptor agonist CT-388 in people living with obesity
No significant changes in HDL cholesterol levels were observed in either group
(1997) Role of melanocortinergic neurons in feeding and the agouti obesity syndrome Nature 385(6612):165168